Positions
- Distinguished Service Professor
-
Mol & Cell Biology-Rosen
Baylor College of Medicine
Houston, TX, US
- Leader, Breast Cancer Program
-
Dan L Duncan Comprehensive Cancer Center
Baylor College of Medicine
Houston, Texas, United States
- Professor
-
Baylor College of Medicine
- Charles C. Bell Professor
-
Molecular and Cellular Biology
Addresses
- Department of Molecular and Cellular Biology (Office)
-
Baylor College of Medicine
One Baylor Plaza N610
Houston, TX, 77030
United States
Phone: (832) 215-9503
jrosen@bcm.edu
Education
- BA from Williams College
- 01/1966 - Williamstown, Massachusetts, United States
- PhD from State University of New York at Buffalo
- 01/1970 - Buffalo, New York, United States
- Post-Doctoral Fellowship at Vanderbilt University School of Medicine
- 01/1972 - Nashville, Tennessee, United States
Honors & Awards
- Marc Dresden Excellence in Graduate Education Award, 1996
- Endocrine Society Edwin B. Astwood Lecture Award 2000
- Barbara & Corbin J. Robertson, Jr. Presidential Award for Excellence in Education, Baylor College of Medicine, 2002
- Michael E. DeBakey, M.D., Excellence in Research Award, 2004.
- Susan G. Komen for the Cure® Brinker Basic Science Award, 2010
- AAAS Fellow, 2016
- AACR Distinguished Lectureship in Breast Cancer Research, 2017
- AACR/SABCS William A McGuire Memorial Lecture Award
- AACR/SABCS (12/2022)
Professional Interests
- Developmental and hormonal regulation of mammary gland gene expression and breast cancer
Professional Statement
Our laboratory has developed a series of extensively characterized and "credentialed" syngeneic models of triple negative breast cancer that are being used in preclinical studies to determine both tumor intrinsic and extrinsic effects on the tumor microenvironment of both targeted therapies using small molecular inhibitors as well as gapmer antisense oligonucleotides. These studies are focused on combinatorial treatment strategies with standard-of care chemotherapy and immunotherapy of both primary tumors and established metastases with the long-term goal of translating these studies into the clinic.
Selected Publications
-
Kim, IS, Welte, T, Gao, Y, Toneff, MJ, Wang, H, Janghorban, M, Zhao, N, Goldstein, A, Sheng, K, Niu, Y, Liu, J, Lo, H-C, Bado, I, Nguyen, T, et al. and Rosen, JM, Zhang, X H-F.. " Immuno-subtyping of breast cancer reveals distinct myeloid cell biology and immunotherapy resistance mechanisms " Nature Cell Biol. 2019 ; 21 : 1113-1126.
Pubmed PMID: 31451770. -
Nguyen, TM, Kabotyanski, EB, Dou, Y, Reineke, LC, Zhang, P, Zhang, X, Malovannaya, A, Jung, SY, Mo, Q, Roarty, K, Chen, Y, Zhang, B, Neilson, JR, Lloyd, RE, Perou, CM, Ellis, MJ and Rosen, JM.. " FGFR1-activated translation of WNT pathway components with structured 5’ UTRs is vulnerable to inhibition of eIF4A-dependent translation initiation " Cancer Res. 2018 ; 78 : 4229-4240.
Pubmed PMID: 29844125. -
Sreekumar A, Toneff MJ, Toh E, Roarty K, Creighton CJ, Belka GK, Lee DK, Xu J, Chodosh LA, Richards JS, Rosen JM. " WNT-Mediated Regulation of FOXO1 Constitutes a Critical Axis Maintaining Pubertal Mammary Stem Cell Homeostasis " Dev Cell. 2017 ; 43 : 436-448.
Pubmed PMID: 29103953. -
Welte, T., Kim, IS, Tian, L, Gao, X, Wang, H., Li, J. Holdman, X.B., Herschkowitz, J.I., Pond, A., Xie, G., Kurley, S, Nguyen, T, et al and Westbrook, T, Rosen, JM. and Zhang, XH. " Oncogenic mTOR signaling recruits myeloid-derived suppressor cells to promote tumor initiation " Nature Cell Biol. 2016 ; 18 : 632-644.
Pubmed PMID: 27183469.
Log In to edit your profile